IL122942A0 - Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them - Google Patents
Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing themInfo
- Publication number
- IL122942A0 IL122942A0 IL12294296A IL12294296A IL122942A0 IL 122942 A0 IL122942 A0 IL 122942A0 IL 12294296 A IL12294296 A IL 12294296A IL 12294296 A IL12294296 A IL 12294296A IL 122942 A0 IL122942 A0 IL 122942A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- arabinofuranosylcytosine
- beta
- esters
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Artificial Filaments (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyamides (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9515279.9A GB9515279D0 (en) | 1995-07-25 | 1995-07-25 | Improved therapeutic agents |
| PCT/NO1996/000179 WO1997005154A1 (en) | 1995-07-25 | 1996-07-12 | Improved therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL122942A0 true IL122942A0 (en) | 1999-05-09 |
Family
ID=10778247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12294296A IL122942A0 (en) | 1995-07-25 | 1996-07-12 | Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them |
| IL122942A IL122942A (en) | 1995-07-25 | 1998-01-15 | Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL122942A IL122942A (en) | 1995-07-25 | 1998-01-15 | Pharmaceutical preparations containing esters of D – ß – 1 - arabinopuranosyl cytosine and some new esters of this type |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6316425B1 (pt) |
| EP (1) | EP0842185B1 (pt) |
| JP (2) | JP4372227B2 (pt) |
| KR (1) | KR100401909B1 (pt) |
| AT (1) | ATE207076T1 (pt) |
| AU (1) | AU714814B2 (pt) |
| CA (1) | CA2227533C (pt) |
| CZ (1) | CZ291612B6 (pt) |
| DE (1) | DE69616074T2 (pt) |
| DK (1) | DK0842185T3 (pt) |
| ES (1) | ES2166900T3 (pt) |
| GB (1) | GB9515279D0 (pt) |
| HU (1) | HU224839B1 (pt) |
| IL (2) | IL122942A0 (pt) |
| MX (1) | MX9800622A (pt) |
| NO (1) | NO313985B1 (pt) |
| NZ (1) | NZ313790A (pt) |
| PL (1) | PL183601B1 (pt) |
| PT (1) | PT842185E (pt) |
| RU (1) | RU2165260C2 (pt) |
| SK (1) | SK283003B6 (pt) |
| TW (1) | TW434251B (pt) |
| UA (1) | UA55389C2 (pt) |
| WO (1) | WO1997005154A1 (pt) |
| ZA (1) | ZA966047B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
| CA2271135A1 (en) * | 1996-11-12 | 1998-05-22 | Medivir Ab | Nucleosides |
| NZ336676A (en) * | 1997-01-24 | 2000-01-28 | Norsk Hydro As | Gemcitabine esters or amides useful as anti-cancer and anti-viral agents |
| US7393862B2 (en) * | 2002-05-17 | 2008-07-01 | Celgene Corporation | Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| JP2007509994A (ja) * | 2003-11-03 | 2007-04-19 | コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド |
| NO324263B1 (no) * | 2005-12-08 | 2007-09-17 | Clavis Pharma Asa | Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser |
| US8497292B2 (en) * | 2005-12-28 | 2013-07-30 | Translational Therapeutics, Inc. | Translational dysfunction based therapeutics |
| EP2205073A4 (en) * | 2007-09-26 | 2013-03-06 | Sinai School Medicine | AZACYTIDINE ANALOGS AND USES THEREOF |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| MX2012005677A (es) * | 2009-11-20 | 2012-08-23 | Clavis Pharma Asa | Formulaciones parentales de derivados de gemcitabina. |
| US8912162B2 (en) | 2010-07-13 | 2014-12-16 | Clavis Pharma Asa | Parenteral formulations of elacytarabine derivatives |
| DK2832740T3 (da) * | 2012-03-28 | 2019-07-15 | Fujifilm Corp | SALT AF 1-(2-DEOXY-2-FLUOR-4-THIO-beta-D-ARABINOFURANOSYL)CYTOSIN |
| US20210052619A1 (en) | 2018-01-15 | 2021-02-25 | Yinuoke Medicine Science And Technology Company Ltd. | Treatments for cachexia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3894000A (en) * | 1971-01-27 | 1975-07-08 | Upjohn Co | Ara-cytidine derivatives and process of preparation |
| CA2079413C (en) | 1991-09-30 | 2003-09-09 | Masakatsu Kaneko | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
| GB9307043D0 (en) | 1993-04-05 | 1993-05-26 | Norsk Hydro As | Chemical compounds |
| US5641758A (en) | 1993-11-10 | 1997-06-24 | Kluge; Michael | Cytarabine derivatives, the preparation and use thereof |
-
1995
- 1995-07-25 GB GBGB9515279.9A patent/GB9515279D0/en active Pending
-
1996
- 1996-07-12 KR KR10-1998-0700463A patent/KR100401909B1/ko not_active IP Right Cessation
- 1996-07-12 PL PL96324690A patent/PL183601B1/pl not_active IP Right Cessation
- 1996-07-12 CZ CZ1998163A patent/CZ291612B6/cs not_active IP Right Cessation
- 1996-07-12 ES ES96926032T patent/ES2166900T3/es not_active Expired - Lifetime
- 1996-07-12 AU AU66335/96A patent/AU714814B2/en not_active Ceased
- 1996-07-12 DK DK96926032T patent/DK0842185T3/da active
- 1996-07-12 IL IL12294296A patent/IL122942A0/xx active IP Right Grant
- 1996-07-12 US US08/983,483 patent/US6316425B1/en not_active Expired - Lifetime
- 1996-07-12 AT AT96926032T patent/ATE207076T1/de active
- 1996-07-12 CA CA002227533A patent/CA2227533C/en not_active Expired - Fee Related
- 1996-07-12 NZ NZ313790A patent/NZ313790A/xx not_active IP Right Cessation
- 1996-07-12 WO PCT/NO1996/000179 patent/WO1997005154A1/en active IP Right Grant
- 1996-07-12 DE DE69616074T patent/DE69616074T2/de not_active Expired - Lifetime
- 1996-07-12 SK SK80-98A patent/SK283003B6/sk not_active IP Right Cessation
- 1996-07-12 EP EP96926032A patent/EP0842185B1/en not_active Expired - Lifetime
- 1996-07-12 PT PT96926032T patent/PT842185E/pt unknown
- 1996-07-12 RU RU98103238/04A patent/RU2165260C2/ru not_active IP Right Cessation
- 1996-07-12 JP JP50750497A patent/JP4372227B2/ja not_active Expired - Fee Related
- 1996-07-12 HU HU9900924A patent/HU224839B1/hu not_active IP Right Cessation
- 1996-07-16 ZA ZA9606047A patent/ZA966047B/xx unknown
- 1996-10-02 TW TW085111996A patent/TW434251B/zh not_active IP Right Cessation
- 1996-12-07 UA UA98020922A patent/UA55389C2/uk unknown
-
1998
- 1998-01-15 IL IL122942A patent/IL122942A/en not_active IP Right Cessation
- 1998-01-21 MX MX9800622A patent/MX9800622A/es not_active IP Right Cessation
- 1998-01-23 NO NO19980296A patent/NO313985B1/no not_active IP Right Cessation
-
1999
- 1999-11-09 US US09/435,641 patent/US6335322B1/en not_active Expired - Fee Related
-
2009
- 2009-07-03 JP JP2009159081A patent/JP5087052B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5278096A (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same | |
| PL324430A1 (en) | Novel inhibitors of pharnesiltransferase, their production and pharmaceutic compositions containing them | |
| PL321710A1 (en) | Novel inhibitors of farnseferase, their production and pharmaceutic compositions containing them | |
| AU1180997A (en) | Novel taxoids, their preparation and pharmaceutical compositions containing them | |
| AU5476396A (en) | Pharmaceutical compositions containing irbesartan | |
| HUP9601698A3 (en) | Pharmaceutical composition of adiabetical activity | |
| EP0811595A4 (en) | HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS | |
| HUP9701690A3 (en) | Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same | |
| ZA965294B (en) | Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them. | |
| AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
| AU7727196A (en) | Oxygen generating compositions | |
| HUP9801356A3 (en) | Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them | |
| WO1996021468A3 (en) | Chemically modified interferon | |
| IL122942A0 (en) | Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them | |
| HUP9801880A3 (en) | Novel cryptophycins, their use and pharmaceutical compositions containing them | |
| GR3033591T3 (en) | Novel taxoids, preparation thereof, and pharmaceutical compositions containing same | |
| AU5402896A (en) | New taxoids, their preparation and pharmaceutical compositions containing same | |
| HK1014137A1 (en) | Benzopyrans and pharmaceutical compositions containing them | |
| IL106290A0 (en) | Enzyme inhibitors,their preparation and pharmaceutical compositions containing them | |
| IL99233A0 (en) | Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them | |
| MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
| AU5994796A (en) | Modified kojibiosides analogues | |
| AU1180897A (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same | |
| HU9700437D0 (en) | Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| AU5994696A (en) | Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| ERR | Corrigendum |
Free format text: IN JOURNAL 9/2006 P. 3455 PATENT APPLICATION NO. 122942 GB 25.7.1995 WO 1997/05154 CORRECT PRIORITYCLAIM CORRECT INTERNATIONAL PUBLICATION NO. TO JULY 24, 2007 |
|
| FF | Patent granted | ||
| KB | Patent renewed |